Culig Z - Search Results

1

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.

Erb HH, Langlechner RV, Moser PL, Handle F, Casneuf T, Verstraeten K, Schlick B, Schäfer G, Hall B, Sasser K, Culig Z, Santer FR. Erb HH, et al. Among authors: culig z. Endocr Relat Cancer. 2013 Aug 23;20(5):677-89. doi: 10.1530/ERC-13-0222. Print 2013 Oct. Endocr Relat Cancer. 2013. PMID: 23913484 Free PMC article.

2

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. Culig Z, et al. Cancer Res. 1994 Oct 15;54(20):5474-8. Cancer Res. 1994. PMID: 7522959

3

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.

Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z. Hobisch A, et al. Among authors: culig z. Cancer Res. 1998 Oct 15;58(20):4640-5. Cancer Res. 1998. PMID: 9788616

4

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.

Culig Z, Hobisch A, Herold M, Hittmair A, Thurnher M, Eder IE, Cronauer MV, Rieser C, Ramoner R, Bartsch G, Klocker H, Konwalinka G. Culig Z, et al. Br J Cancer. 1998 Oct;78(8):1004-11. doi: 10.1038/bjc.1998.619. Br J Cancer. 1998. PMID: 9792142 Free PMC article.

5

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.

Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H. Putz T, et al. Among authors: culig z. Cancer Res. 1999 Jan 1;59(1):227-33. Cancer Res. 1999. PMID: 9892211

6

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.

Cronauer MV, Nessler-Menardi C, Klocker H, Maly K, Hobisch A, Bartsch G, Culig Z. Cronauer MV, et al. Among authors: culig z. Br J Cancer. 2000 Jan;82(1):39-45. doi: 10.1054/bjoc.1999.0874. Br J Cancer. 2000. PMID: 10638964 Free PMC article.

7

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models.

Nessler-Menardi C, Jotova I, Culig Z, Eder IE, Putz T, Bartsch G, Klocker H. Nessler-Menardi C, et al. Among authors: culig z. Prostate. 2000 Oct 1;45(2):124-31. doi: 10.1002/1097-0045(20001001)45:2<124::aid-pros6>3.0.co;2-7. Prostate. 2000. PMID: 11027411

8

Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.

Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z. Hobisch A, et al. Among authors: culig z. Clin Cancer Res. 2001 Sep;7(9):2941-8. Clin Cancer Res. 2001. PMID: 11555613

9

Androgen receptors in prostate cancer.

Culig Z, Klocker H, Bartsch G, Hobisch A. Culig Z, et al. Endocr Relat Cancer. 2002 Sep;9(3):155-70. doi: 10.1677/erc.0.0090155. Endocr Relat Cancer. 2002. PMID: 12237244 Review.

10

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.

Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, Comuzzi B, Bartsch G, Hobisch A, Culig Z. Steiner H, et al. Among authors: culig z. Am J Pathol. 2003 Feb;162(2):655-63. doi: 10.1016/S0002-9440(10)63859-X. Am J Pathol. 2003. PMID: 12547723 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters